Sangamo Therapeutics (SGMO), Mogrify announce collaboration and exclusive license agreement for Mogrify's iPSC- and ESC-derived regulatory T cells
Go back to Sangamo Therapeutics (SGMO), Mogrify announce collaboration and exclusive license agreement for Mogrify's iPSC- and ESC-derived regulatory T cells| Sangamo Biosciences, Inc. (NASDAQ: SGMO) | Delayed: 0.50 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.50 | 52 Week High | $9.91 | |||
| Open | $0.50 | 52 Week Low | $3.10 | |||
| Day High | $0.50 | P/E | N/A | |||
| Day Low | $0.50 | EPS | $-0.48 | |||
| Volume | 102 | |||||
